RecruitingNCT01905826
Natural History Study of GATA2 Deficiency and Related Disorders
Studying Autosomal dominant aplasia and myelodysplasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Principal Investigator
- Steven M Holland, M.D.National Institute of Allergy and Infectious Diseases (NIAID)
- Enrollment
- 600 enrolled
- Eligibility
- 2-100 years · All sexes
- Timeline
- 2013
Study locations (1)
- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Collaborators
Baylor College of Medicine · UCSF Diabetes Center and Division of Infectious Diseases · Department of Molecular and Cell Biology · New York Genome Center
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01905826 on ClinicalTrials.govOther trials for Autosomal dominant aplasia and myelodysplasia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT06090669Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 DeficiencyNational Cancer Institute (NCI)
- RECRUITINGNANCT04781790French National Registry of Bone Marrow FailuresAssistance Publique - Hôpitaux de Paris
- RECRUITINGNANCT02958462Pre-myeloid Cancer and Bone Marrow Failure Clinic StudyMayo Clinic
See all trials for Autosomal dominant aplasia and myelodysplasia →